ARDX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ardelyx Inc (ARDX) is not a strong buy for a beginner investor with a long-term focus at this moment. While the stock has positive analyst ratings and potential catalysts like a new patent, the financial performance shows a concerning drop in net income and EPS. Additionally, hedge funds are selling, and there is no significant insider or congressional trading activity to suggest confidence. The technical indicators and options data do not strongly support a buy decision right now.
The MACD is positive but contracting, RSI is neutral at 69.505, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 6.129, with resistance at 6.425 and support at 5.833.
Analysts have raised price targets significantly, citing strong execution in product launches and a new patent with long-term potential. Gross margin has increased to 91.34%, showing operational efficiency.
Hedge funds are selling heavily, with a 129.11% increase in selling activity last quarter. Net income and EPS have dropped significantly, and there is no recent news or congressional trading activity to support a bullish case.
In Q4 2025, revenue increased by 7.82% YoY to $125.2M, and gross margin improved to 91.34%. However, net income dropped by 108.76%, resulting in a net loss of $407K, and EPS fell to 0.
Analysts are optimistic, with multiple firms raising price targets (e.g., H.C. Wainwright to $18, Jefferies to $15). They highlight strong product execution and long-term growth potential driven by new patents and market opportunities.
